Observed arrival · 2026-09-26
Readthrough turns biotech filings into cited briefings
A paid monitoring service that summarizes FDA, SEC, and ClinicalTrials.gov updates for watched biotech companies, drugs, and targets.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Biotech researchers tracking companies, drugs, and trials
- Worth noticing
- SEC filings are polled every ten minutes during U.S. market hours; the site says its record begins 90 days before launch.
Field notes
Users can build watch lists from companies, drugs, and targets, or begin with curated areas such as oncology and rare disease. The homepage says the service stores source URLs, versions ClinicalTrials.gov changes, and checks SEC filings on a faster schedule during U.S. market hours than overnight. Its stated archive begins 90 days before launch; older material remains available through linked source records.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
⊠LoginAccess appeared gated
$PaidCommerce or pricing visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
ƒJavaScriptBrowser-side code central
One card from the complete issue